Aralez Pharmaceuticals Inc (TSE:ARZ) insider James Patrick Tursi sold 9,960 shares of the stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of C$2.50, for a total transaction of C$24,900.00.

Aralez Pharmaceuticals Inc (TSE:ARZ) traded down 5.88% during midday trading on Friday, reaching $2.88. 29,031 shares of the company traded hands. The firm’s 50 day moving average price is $2.24 and its 200 day moving average price is $2.24. The firm’s market capitalization is $192.52 million. Aralez Pharmaceuticals Inc has a 12 month low of $1.46 and a 12 month high of $7.35.

TRADEMARK VIOLATION NOTICE: “James Patrick Tursi Sells 9,960 Shares of Aralez Pharmaceuticals Inc (ARZ) Stock” was posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/james-patrick-tursi-sells-9960-shares-of-aralez-pharmaceuticals-inc-arz-stock/1612605.html.

About Aralez Pharmaceuticals

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Insider Buying and Selling by Quarter for Aralez Pharmaceuticals (TSE:ARZ)

Receive News & Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.